Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Aprameya Engineering IPO
Price Band
₹56.0–58.0
Issue Size
₹29.23 Cr
Lot Size
2,000 shares
Min Investment
₹116,000
GMP
+₹23.0 (39.66%)
Issue Price
₹58.0
Subject to Sauda
₹35000
Paid only if allotted
Aprameya Engineering IPO AI Summary
- Aprameya Engineering IPO is listed on NSE SME in the Medical Equipment & Supplies sector.
- Price band: ₹56.0–₹58.0 per share, lot size 2,000 shares (min. investment ₹116,000).
- Subscription window: 25 Jul–29 Jul 2024, listing on 01 Aug 2024.
- Current GMP is +₹23.0 (39.66%), an estimated listing price of ₹81 — unofficial and can change daily.
Aprameya Engineering Limited is focused on providing critical healthcare infrastructure and equipment. Despite a decline in financial performance over the last few years, the company is positioned in a growing sector. Investors should carefully consider the financials and their investment strategy before participating in the IPO.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Aprameya Engineering IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 29 Jul 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Aprameya Engineering IPO Grey Market Premium (GMP) Today
GMP
+₹23.0
GMP %
+39.66%
Est. Listing
₹81.0
Updated: 25 Jul 2026 14:05
About the Company
Incorporated in September 2003, Aprameya Engineering Limited installs and maintains Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centres. They provide these services on a turnkey basis and also supply high-value healthcare and diagnostic equipment to private hospitals, government hospitals, and medical practitioners. The company's products can be segregated into two categories:- Establishing healthcare infrastructure within hospitals and medical care centers. Dealing in high-value medical equipment Since 2020, the company has been setting up ICUs and operation theatres and has installed around 2000 critical care beds, including ICUs, NICUs, and PICUs, Modular operation theatres are being established throughout the state of Rajasthan. The company has four warehouses: two in Memnagar, Ahmedabad, one in Prahladnagar, Ahmedabad and the fourth one on Ashram Road, Ahmedabad. The company provides a wide range of medical equipment and solutions, such as an Electrosurgical Generator, Electrosurgical Unit, CO2 Insufflator, LED Surgery Light, Surgical and medical Examination Light, ICU Respiratory Monitoring System, ICU Ventilation System, Anesthesia Workstation, Jaundice Meter, Anesthesia Machine, and Harmonic Scale. As of August 31, 2023, the company employed 44 permanent staff members responsible for day-to-day business operations, marketing, and accounting functions. business operations, marketing, and accounting functions.
Company Financials (₹ Cr)
As of 2024-03-31
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 75.60 | 61.89 | 48.71 |
| Total Income | 65.62 | 78.33 | 200.26 |
| Profit After Tax | 3.46 | 5.37 | 16.62 |
| NET Worth | 23.37 | 19.92 | 14.53 |
| Reserves and Surplus | 9.37 | 5.92 | 7.53 |
| Total Borrowing | 42.05 | 28.74 | 13.68 |
Key Ratios
EPS
₹2.47
NAV
₹16.69
ROE
15.97%
ROCE
9.60%
RoNW
14.79%
P/B Value
3.48
P/E Ratio
23.49
Market Cap
₹110.43 Cr
PAT Margin
5.30%
Debt/Equity
1.80
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Aprameya Engineering Limited This IPO | 16.69 | 14.79% | 15.12 | 3.84 | 3.84 |
Promoters
Saurabh Kishorbhai Bhatt and Chetan Mohan Joshi
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 To meet incremental working capital requirements 21.00 2 General Corporate Purposes 3.68 Total 24.68
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹200.26 Cr in the period ending 31 Mar 2022, but it fell to ₹78.33 Cr by 31 Mar 2023, and further decreased to ₹65.62 Cr by 31 Mar 2024. This indicates a declining trend in revenue over these periods.
Profit Trend
Profit After Tax was ₹16.62 Cr in the period ending 31 Mar 2022, decreasing to ₹5.37 Cr by 31 Mar 2023, and further down to ₹3.46 Cr by 31 Mar 2024. This shows a consistent decline in profitability across these periods.
Valuation
The company has an EPS of ₹3.84 and is priced at ₹58.0 per share, implying a P/E ratio of approximately 15.12 at the issue price. This is lower than the P/E ratio of 23.49, indicating that it may be priced more attractively compared to its peers.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the price at which the IPO is expected to list in the stock market compared to its issue price. A positive GMP suggests that the IPO is in demand and may list at a higher price than the issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their personal risk tolerance and investment strategy. It is important to consider the company's financial performance and market conditions before making a decision.
Who May Want to Wait
Investors who are risk-averse or prefer stable income may want to avoid this IPO, especially given the recent decline in revenue and profits. It's essential to assess one's investment goals and risk appetite.
IPO Timeline, Explained
The IPO opens for subscription on July 25, 2024, and closes on July 29, 2024. Allotment of shares will be done on July 30, 2024, and the listing is expected on August 1, 2024.
Listing Gains — The Risk
Listing gains are not guaranteed and can be influenced by market conditions, investor sentiment, and the overall performance of the company post-IPO. Investors should be prepared for the possibility of price fluctuations on the listing day.
This evaluation is generated from Aprameya Engineering's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Aprameya Engineering IPO GMP today?
Aprameya Engineering IPO GMP today is +₹23.0 (39.66%), indicating an estimated listing price of ₹81. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Aprameya Engineering IPO?
The price band of Aprameya Engineering IPO is ₹56.0–₹58.0 per share.
When does Aprameya Engineering IPO open and close?
Aprameya Engineering IPO opens on 25 July 2024 and closes on 29 July 2024.
When does Aprameya Engineering IPO list on the stock exchange?
Aprameya Engineering IPO listed on 01 August 2024 at ₹81.0.
What is the lot size for Aprameya Engineering IPO?
The lot size for Aprameya Engineering IPO is 2000 shares, requiring a minimum investment of ₹116,000.
What is the lot size for this IPO?
The lot size for Aprameya Engineering's IPO is 2000 shares.
What is the minimum investment required?
The minimum investment required is ₹116,000.
What is the price band for the IPO?
The price band for the IPO is ₹56.0 to ₹58.0.
When is the listing date for the IPO?
The listing date for the IPO is August 1, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium price at which the IPO shares will list compared to the issue price.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
25 Jul 2024
Close
29 Jul 2024
Allotment
30 Jul 2024
Listing
01 Aug 2024
Similar IPOs in Medical Equipment & Supplies
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Aprameya Engineering?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.